FI945781A0 - Uudet pregnaanirungon sisältävät steroidit, niitä sisältävät farmaseuttiset koostumukset ja menetelmä niiden valmistamiseksi - Google Patents

Uudet pregnaanirungon sisältävät steroidit, niitä sisältävät farmaseuttiset koostumukset ja menetelmä niiden valmistamiseksi

Info

Publication number
FI945781A0
FI945781A0 FI945781A FI945781A FI945781A0 FI 945781 A0 FI945781 A0 FI 945781A0 FI 945781 A FI945781 A FI 945781A FI 945781 A FI945781 A FI 945781A FI 945781 A0 FI945781 A0 FI 945781A0
Authority
FI
Finland
Prior art keywords
preparation
pharmaceutical compositions
steroids
compositions containing
novel pregnane
Prior art date
Application number
FI945781A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI945781A (fi
Inventor
Sandor Maho
Zoltan Tuba
Aniko Gere
Pal Vittay
Bela Kiss
Eva Palosi
Laszlo Szporny
Czinege Erzsebet Francsicsne
Mezei Anna Boorne
Gabor Balogh
Sandor Goeroeg
Original Assignee
Richter Gedeon Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszet filed Critical Richter Gedeon Vegyeszet
Publication of FI945781A0 publication Critical patent/FI945781A0/fi
Publication of FI945781A publication Critical patent/FI945781A/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48—Two nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/50—Three nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
FI945781A 1992-06-09 1994-12-08 Uudet pregnaanirungon sisältävät steroidit, niitä sisältävät farmaseuttiset koostumukset ja menetelmä niiden valmistamiseksi FI945781A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU9201910A HU212308B (en) 1992-06-09 1992-06-09 Process for producing novel pregnane steroids and pharmaceutical compositions containing the same
PCT/HU1993/000035 WO1993025570A1 (en) 1992-06-09 1993-06-08 Novel steroids with pregnane skeleton, pharmaceutical compositions containing them and process for preparing same

Publications (2)

Publication Number Publication Date
FI945781A0 true FI945781A0 (fi) 1994-12-08
FI945781A FI945781A (fi) 1994-12-08

Family

ID=10982020

Family Applications (1)

Application Number Title Priority Date Filing Date
FI945781A FI945781A (fi) 1992-06-09 1994-12-08 Uudet pregnaanirungon sisältävät steroidit, niitä sisältävät farmaseuttiset koostumukset ja menetelmä niiden valmistamiseksi

Country Status (17)

Country Link
US (1) US5547949A (ru)
EP (1) EP0646126A1 (ru)
JP (1) JPH07507792A (ru)
KR (1) KR950701933A (ru)
AU (1) AU4352393A (ru)
CA (1) CA2136546A1 (ru)
CZ (1) CZ308094A3 (ru)
EE (1) EE9400071A (ru)
FI (1) FI945781A (ru)
HR (1) HRP930956A2 (ru)
HU (1) HU212308B (ru)
IL (1) IL105943A0 (ru)
NO (1) NO944749L (ru)
RU (1) RU94046369A (ru)
SI (1) SI9300311A (ru)
WO (1) WO1993025570A1 (ru)
ZA (1) ZA934036B (ru)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE473759T1 (de) 1998-05-22 2010-07-15 Univ Leland Stanford Junior Bifunktionelle moleküle sowie darauf basierende therapien.
US7081470B2 (en) * 2001-01-31 2006-07-25 H. Lundbeck A/S Use of GALR3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods
US20040127502A1 (en) * 2001-01-31 2004-07-01 Synaptic Pharmaceutical Corporation Use of GAL3 antagonist for treatment of depression
MY141867A (en) * 2002-06-20 2010-07-16 Vertex Pharma Substituted pyrimidines useful as protein kinase inhibitors
CN103259027A (zh) 2005-04-28 2013-08-21 普罗透斯数字保健公司 药物信息系统
JP2009508494A (ja) 2005-09-16 2009-03-05 ラプトール ファーマシューティカル インコーポレイテッド Ｃｒを含むタンパク質に対して特異的な受容体−結合タンパク質（ｒａｐ）変異体を含む組成物およびその使用
NL2000323C2 (nl) * 2005-12-20 2007-11-20 Pfizer Ltd Pyrimidine-derivaten.
KR101591482B1 (ko) 2008-05-28 2016-02-03 레베라겐 바이오파마 인코포레이티드 질환의 치료를 위한 ＮＦ-κＢ 의 비호르몬성 스테로이드 조절제
PT2398500T (pt) 2009-02-20 2019-06-14 2 Bbb Medicines B V Sistema de entrega de medicamentos à base de glutationas
TWI556839B (zh) 2009-05-06 2016-11-11 研究室護膚股份有限公司 包含活性劑－磷酸鈣粒子複合物之皮膚遞送組成物及其使用方法
EP2556083A4 (en) 2010-04-05 2013-12-04 Validus Biopharma Inc NONHORMONAL STEROID MODULATORS OF NF-KAPPA-B FOR DISEASE TREATMENT
US10799514B2 (en) 2015-06-29 2020-10-13 Reveragen Biopharma, Inc. Non-hormonal steroid modulators of NF-kappa beta for treatment of disease
US11382922B2 (en) 2019-03-07 2022-07-12 Reveragen Biopharma, Inc. Aqueous oral pharmaceutical suspension compositions

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5099019A (en) * 1985-09-12 1992-03-24 Upjohn Company Amines useful in producing pharmaceutically active CNS compounds
ES2078890T3 (es) * 1986-10-09 1996-01-01 Upjohn Co Amino esteroides en c20 a c26.
FR2644787B1 (fr) * 1989-03-22 1995-02-03 Roussel Uclaf Nouveaux steroides 21 aminosubstitues, leur procede de preparation et les intermediaires de ce procede, leur application comme medicaments et les compositions pharmaceutiques les contenant
FR2644789B1 (fr) * 1989-03-22 1995-02-03 Roussel Uclaf Nouveaux steroides 19-nor, 3-ceto comportant une chaine en 17 aminosubstituee, leur procede de preparation et les intermediaires de ce procede, leur application comme medicaments et les compositions pharmaceutiques les contenant
JPH05503705A (ja) * 1990-01-26 1993-06-17 ジ・アップジョン・カンパニー ５―酸素化―２，４，６―トリアミノピリミジン類

Also Published As

Publication number Publication date
HU9201910D0 (en) 1992-09-28
HU212308B (en) 1996-05-28
HUT64562A (en) 1994-01-28
SI9300311A (sl) 1993-12-31
NO944749D0 (no) 1994-12-08
IL105943A0 (en) 1993-10-20
WO1993025570A1 (en) 1993-12-23
US5547949A (en) 1996-08-20
JPH07507792A (ja) 1995-08-31
FI945781A (fi) 1994-12-08
CZ308094A3 (en) 1995-11-15
AU4352393A (en) 1994-01-04
CA2136546A1 (en) 1993-12-23
RU94046369A (ru) 1996-09-27
EE9400071A (et) 1995-12-15
ZA934036B (en) 1994-01-06
EP0646126A1 (en) 1995-04-05
HRP930956A2 (hr) 1995-02-28
NO944749L (no) 1995-02-08
KR950701933A (ko) 1995-05-17

Similar Documents

Publication Publication Date Title
HUT72639A (en) Substituted thiazolidinedione derivatives, pharmaceutical compositions containing them and process for their preparation
EE9700333A (et) Substitueeritud 4-fenüülaminotiasoolid, nende valmistamise meetod ja neid sisaldavad farmakoloogilised kompositsioonid
IL116486A0 (en) Novel piperidine derivatives processes for their preparation and pharmaceutical compositions containing them
HUT64734A (en) Anthraquinone-derivativdes, process for preparing them and pharmaceutical compositions containing them
IL85741A0 (en) Substituted 9-amino-tetrahydroacridines and related compounds,a process for their preparation and pharmaceutical compositions containing them
EP0470617A3 (en) 17-substituted corticoid-17-alkylcarbonates, a process for their preparation and pharmaceutical compositions containing them
FI945781A (fi) Uudet pregnaanirungon sisältävät steroidit, niitä sisältävät farmaseuttiset koostumukset ja menetelmä niiden valmistamiseksi
EE9400070A (et) Bioloogiliselt aktiivsed eburnameniini derivaadid, neid sisaldavad farmatseutilised segud ja nende valmistamise protsess
FI960316A (fi) Oksatiolaanit, menetelmä niiden valmistamiseksi ja niitä sisältävät farmaseuttiset koostumukset
HUT72319A (en) Epoxy-succinic acid derivatives, pharmaceutical compositions containing them and process for their preparation
FI956278A (fi) Substituoituja 4-fenyylitiatsolijohdannaisia, menetelmä niiden valmistamiseksi ja niitä sisältäviä farmaseuttisia koostumuksia
ZA92299B (en) Compounds having an aryltriazine structure,a process for their preparation,and pharmaceutical compositions comprising them
FI951561A0 (fi) Uudet 17 -substituoidut 4-androstaanijohdannaiset, niitä sisältävät farmaseuttiset koostumukset ja menetelmä niiden valmistamiseksi
IL93477A0 (en) Steroid derivatives,pharmaceutical compositions containing them and process for their preparation
AU6190594A (en) New substituted benzodioxins, a process for their preparation and pharmaceutical compositions containing them
IL107994A0 (en) Steroids process for their preparation and pharmaceutical compositions containing them
EP0418020A3 (en) Cephalosporinderivatives, process for their preparation and pharmaceutical compositions
AU4756693A (en) 1-heteroarylazetidines and -pyrrolidines, process for their preparation and pharmaceutical compositions containing them
FI942675A0 (fi) Uudet substituoidut oksatsinoisokinoliinijohdannaiset, niitä sisältävät farmaseuttiset koostumukset sekä menetelmä niiden valmistamiseksi
IL90219A0 (en) Hydrazinocarbonyloxylabdanes,a process for their preparation and pharmaceutical compositions containing them
FI972129A0 (fi) 6-metoksi-1H-bentsotriatsoli-5-karboksamidijohdannaisia, menetelmä niiden valmistamiseksi ja niitä sisältäviä lääkekoostumuksia
AU672791B2 (en) N-derivatives of (phenylethyl-beta-ol) amine, a process for their preparation and pharmaceutical compositions containing the same
GB9311927D0 (en) Dihydropyridine derivatives,process for their preparation,pharmaceutical compositions containing same and the use thereof for a therapeutic purpose
AU3219693A (en) New 1,4-dihydropyridine compounds, a process for their preparation and pharmaceutical compositions containing them
IL87678A0 (en) N-(substituted alkylidene)fused-bicycloalkylidene or heteroalkylidene quinolinamines,a process for their preparation and pharmaceutical compositions containing same

Legal Events

Date Code Title Description
FD Application lapsed